Advanced Tissue Sciences - Versionsgeschichte

WikiAdmin: REFjournal uses key

2021-11-28T10:30:33Z

REFjournal uses <init> key

← Nächstältere Version		Version vom 28. November 2021, 10:30 Uhr
Zeile 73:		Zeile 73:
	\|title=Biotech's Big Discovery		\|title=Biotech's Big Discovery
	\|last=Hall		\|last=Hall
	\|~~first~~=~~C.T.~~		\|init=CT
	\|journal=San Francisco Chronicle		\|journal=San Francisco Chronicle
	\|date=1996-10-25		\|date=1996-10-25

WikiAdmin: REFbook uses key

2021-11-27T10:17:43Z

REFbook uses <init> key

← Nächstältere Version		Version vom 27. November 2021, 10:17 Uhr
Zeile 54:		Zeile 54:
	\|last=Pitta		\|last=Pitta
	\|first=Julie		\|first=Julie
			\|init=J
	\|date=1993-05-10		\|date=1993-05-10
	\|title=Biosynthetics		\|title=Biosynthetics

WikiAdmin am 2. Februar 2020 um 15:05 Uhr

2020-02-02T15:05:12Z

← Nächstältere Version		Version vom 2. Februar 2020, 15:05 Uhr
Zeile 1:		Zeile 1:
	~~{{NYT en}}~~
	<!-- [[Image:Advanced Tissue Sciences.jpg\|right\|thumb\|]] -->		<!-- [[Image:Advanced Tissue Sciences.jpg\|right\|thumb\|]] -->
	'''Advanced Tissue Sciences''' ~~is a corporation based~~ in La Jolla, CA. ~~They are the makers of~~ [[Dermagraft-TC]], ~~which is an artifical skin created from harvested foreskins from infant circumcision~~.<ref name='Advanced Biohealing, 2010'>{{REFweb		'''Advanced Tissue Sciences''' ist ein Unternehmen mit Sitz in La Jolla, CA. Sie sind die Hersteller von [[Dermagraft-TC]], einer künstlichen Haut, die aus gesammelten Vorhäuten von Neugeborenen-Beschneidungen hergestellt wird.<ref name='Advanced Biohealing, 2010'>{{REFweb
	\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\|last=		\|last=
Zeile 10:		Zeile 9:
	\|url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/
	\|accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> ~~They are also the makers of~~ [[NouriCel]], ~~another product made from harvested foreskins~~,<ref name='Acroposthion 2011'>{{REFweb		}}</ref> Sie sind zudem die Hersteller von [[NouriCel]], einem anderen Produkt aus gesammelten Vorhäuten,<ref name='Acroposthion 2011'>{{REFweb
	\|quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...		\|quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
	\|last=		\|last=
Zeile 19:		Zeile 18:
	\|url=http://www.acroposthion.com/acroposthion_019.htm		\|url=http://www.acroposthion.com/acroposthion_019.htm
	\|accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> ~~and one of the main ingredients of~~ [[SkinMedica]]'s [[TNS Recovery Complex]] ~~product~~.<ref name='SkinMedica 2011'>{{REFweb		}}</ref> und einer der Hauptbestandteile von [[SkinMedica]]s Produkt [[TNS Recovery Complex]].<ref name='SkinMedica 2011'>{{REFweb
	\|quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.		\|quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
	\|last=		\|last=
Zeile 30:		Zeile 29:
	}}</ref>		}}</ref>

	== ~~Earnings~~ ==		== Einkünfte ==

	Dermagraft-TC is FDA ~~approved,~~<ref>{{REFweb		Dermagraft-TC ist von der FDA zugelassen<ref>{{REFweb
	\|quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.		\|quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
	\|last=		\|last=
Zeile 50:		Zeile 49:
	\|url=http://www.highbeam.com/doc/1G1-47248437.html		\|url=http://www.highbeam.com/doc/1G1-47248437.html
	\|accessdate=2011-05-07		\|accessdate=2011-05-07
	}}</ref> ~~and it sells for about $~~3,~~000 per square foot and one foreskin contains enough genetic material to grow~~ 250,000 ~~square feet of skin~~.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref>		}}</ref> und wird für ca. 3.000 US-Dollar pro Quadratfuß (ca. 929 Quadratzentimeter) verkauft, wobei eine Vorhaut genügend genetisches Material enthält, um 250.000 Quadratfuß Haut zu erzeugen.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref>

	Advanced Tissue Sciences ~~has sold about $~~1 ~~million worth of cultured dermis to~~ Proctor & Gamble, Helene Curtis, ~~and other such businesses for pre-market testing~~. Advanced Tissue Science~~'s foreskin~~-~~derived merchandise held a $32 million stock offering in the beginning of 1992~~.<ref>{{REFbook		Advanced Tissue Sciences hat so erzeugte künstliche Haut im Wert von etwa 1 Million US-Dollar an Proctor & Gamble, Helene Curtis und andere Unternehmen verkauft, um sie vor dem Markteintritt zu testen. Die von Advanced Tissue Science hergestellte Ware aus Vorhaut hielt Anfang 1992 ein Aktienangebot von 32 Millionen US-Dollar.<ref>{{REFbook
	\|last=Pitta		\|last=Pitta
	\|first=Julie		\|first=Julie
Zeile 70:		Zeile 69:
	}}</ref>		}}</ref>

	In 1996 ~~alone,~~ Advanced Tissue Sciences ~~could boast of a healthy $~~663.~~9 million market capitalization performance~~.<ref>Biotech's Big Discovery. ~~Hall CT~~. San Francisco Chronicle~~. October~~ 25~~, 1996:~~ E1, E4.</ref>		Allein 1996 konnte Advanced Tissue Sciences eine solide Marktkapitalisierungsleistung von 663,9 Mio. USD vorweisen.<ref>{{REFjournal
			\|title=Biotech's Big Discovery
			\|last=Hall
			\|first=C.T.
			\|journal=San Francisco Chronicle
			\|date=1996-10-25
			\|pages=E1, E4
			}}</ref>

	{{REF}}		{{REF}}

WikiAdmin: Die Seite wurde neu angelegt: „{{NYT en}} '''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the mak…“

2019-11-17T16:59:18Z

Die Seite wurde neu angelegt: „{{NYT en}}  '''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the mak…“

Neue Seite

{{NYT en}}

'''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
|last=
|first=
|publisher=Advanced Biohealing, Inc.
|date=
|title=Dermagraft-TC: Overview
|url=http://www.dermagraft.com/about/overview/
|accessdate=2011-03-06
}}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{REFweb
|quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
|last=
|first=
|publisher=Acroposthion.com
|date=
|title=The Foreskin Mafia
|url=http://www.acroposthion.com/acroposthion_019.htm
|accessdate=2011-03-06
}}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb
|quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
|last=
|first=
|publisher=SkinMedica
|date=2002-02-12
|title=SkinMedica Introduces TNS Recovery Complex
|url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex
|accessdate=2011-03-06
}}</ref>

== Earnings ==

Dermagraft-TC is FDA approved,<ref>{{REFweb
|quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
|last=
|first=
|publisher=MediLexicon International Ltd
|date=2011
|title=Dermagraft-TC: General Information: Advanced Tissue Sciences
|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
|accessdate=2011-05-07
}}</ref><ref>{{REFweb
|quote=the Food and Drug Administration has approved Dermagraft-TC
|last=
|first=
|publisher=HighBeam Research
|date=1997-03-28
|title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
|url=http://www.highbeam.com/doc/1G1-47248437.html
|accessdate=2011-05-07
}}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref>

Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.<ref>{{REFbook
|last=Pitta
|first=Julie
|date=1993-05-10
|title=Biosynthetics
|url=
|editor=
|edition=
|volume=
|chapter=
|pages=170-171
|location=
|publisher=Forbes
|isbn=
|accessdate=
|note=The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
}}</ref>

In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.<ref>Biotech's Big Discovery. Hall CT. San Francisco Chronicle. October 25, 1996: E1, E4.</ref>

{{REF}}

[[Kategorie:Finanzieller Vorteil]]

[[Kategorie:Von IntactWiki]]

[[en:{{FULLPAGENAME}}]]